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Abstract
Introduction. Skin cancer is one of many kinds of cancer which incidence increases globally. Basal cell carcinoma (BSC) and squamous cell
carcinoma (SCC) are the most common prevalence of non–melanoma skin cancer, and also are the most common cancer among skin cancer. The
main therapy for such skin cancer is wide excision within its safety margin added by adjuvant therapy. Despite adequate therapy, people with skin
cancer still have a risk of recurrence. This study assesses the prognostic factors of recurrence among people with non–melanoma skin cancer who
underwent wide excision surgery.
Method. This study was a retrospective cohort with survival analysis. The patient's data who underwent wide excision surgery were from
Perhimpunan Ahli Bedah Onkologi Indonesia (PERABOI) registry and medical record from Oncology Surgery Division in RSCM from January
2012–December 2015. Data selection was done based on inclusion and exclusion criteria.
Results. There were 187 patients with non–melanoma skin cancer who underwent wide excision surgery; the recurrence was detected on 15% of
the case. Most of the patients were ≥45 years old with the most common histopathological feature of the skin cancer was basal cell carcinoma. We
did a survival analysis with Cox regression and the result was previous history of skin cancer (RR 6.903; 95% CI 2.925–16.292), perineural
invasion (HR 3.818; 95% CI 1.561–9.340), location of the lesion (HR 0.071; 95% CI 0.022–0.228), and size of the tumor (HR 1.842; 95% CI
1.244–2.729) was the factors that increased recurrence.
Conclusion. History of previous skin cancer, perineural invasion, location of the lesion, and size of the tumor were the prognostic factors for
recurrence among patients with non–melanoma skin cancer who underwent wide excision surgery.
Keywords: non–melanoma skin cancer, basal cell carcinoma, recurrence, squamous cell carcinoma, wide excision surgery

Introduction
Basal cell carcinoma (BSC) and squamous cell carcinoma (SCC)
are the most common non–melanoma skin cancer group, as well as
the most common malignant tumor found1,2 contributed less than
0.1% mortality of cancer.3,4,5 Aside from death, cancer–related
diseases led the patient suffered; pain and discomfort arising from
cancer, the side effects of treatment. In addition, the high burden of
costs is the things contribute to this suffering.
Wide excision with a safety margin in accordance with
histopathology type completed by the adjuvant therapy is the
treatment for skin cancer. However, the risk of recurrence that may
found let the suffering increased. A cohort study of Margaret et al
(2011) in the United States reporting the recurrence rate of 4.0%.6
Study of Khan et al (2014) showed that age, tumor size, immune
conditions, and modality of therapy were the affecting factors for the
recurrence. Study of the National Comprehensive Cancer Network
reporting tumor location and size, tumor boundary, previous cancer
history, patient immunological status, perineural involvement, and
tumor histopathology subtype were the predictors of recurrence.6,9

Investigations on the affecting factors of the recurrence have been
widely reported. In contrast, the recurrence rates and affecting
factors in Indonesia have not been reported. Thus, the recurrence of
non–melanoma skin cancer following wide excision was the aim of
the study
Method
A retrospective cohort study with survival cox analysis proceeded to
find out the association of age, tumor size, previous cancer history,
perineural invasion, histopathology of skin cancer, and predilection
to the recurrence in patients underwent wide excision in Division of
Oncology Surgery in CMGH during the period of 2012 to 2015.
Data collected from Perhimpunan Ahli Bedah Onkologi Indonesia
(PERABOI) registry and medical record from Oncology Surgery
Division at CMGH were subjected to statistical analysis. Chi-square
was used to determine the correlation of risk factors with the
recurrence, Fischer test was the alternative if the analysis were not
qualified for the Chi-square test. The relative risk (RR) describes the
correlation of each variable to the recurrence.
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Results

In the observation period (2012–2015) there were 381 cases of
skin cancer recorded. Out of 213 non–melanoma, a total of 187
subjects with complete data enrolled in the study. Mostly
(87.2%), the age of the subject of ≥45 years and 7% with a
history of cancer in the family.
Table 1. Distribution of demographic characteristics of skin cancer
in the period of January 2012 – December 2015 (n = 187)
Variable
Age
− <45 years
− ≥ 45 years
Occupation
− Indoor
− Outdoor
Family history of cancer
− Yes
− No

Total (%)
24 (12.8)
163 (87.2)
114 (61.0)
73 (39.0)
13 (7.0)
174 (93.0)

Table 2. Distribution of clinical characteristics of skin cancer in
the period of January 2012 – December 2015
Variable
Total (%)
Age
− <45 years
24 (12.8)
− ≥45 years
163 (87.2)
Previous cancer
− Yes
− No
Histopathology of skin cancer
− BSC
− SCC
Cancer–related
symptoms
− Present
− Absent
Predilection

21 (11.2)
166 (88.8)
98 (52.4)
89 (47.6)

neurological
73 (39)
114 (61)

<2 cm
>2≤ 5 cm
>5 cm

Table 3. Relationship of clinical characteristics of skin cancer
patients with recurrence at RSCM during period January 2012 –
December 2015
Variable
Age
−
<45 years
−
≥45 years
History of
previous
cancer
−
Yes
−
No
Histopathology
−
SCC
−
BSC
Cancer–related
neurological
symptoms
−
Present
−
Absent
Predilection
−
High risk
−
Low risk
Tumor size
−
≤5 cm
−
>5 cm

− Face
134 (71.7)
− Trunk and upper extremities 14 (7.5)
− Lower extremities
39 (20.9)
Tumor size
−
−
−

Subjects with BSC were found predominant (52.4%) with the
predilection in the face; of which is the predisposing area of
high–risk skin cancer. Among the recorded risk factors to the
recurrence in this non–melanoma underwent wide excision
surgery, there was only the variable of age showing nonrelated
to recurrence (p = 0.258; RR 0.569; 95% CI 0.206–1.570) (table
3). Based on the results using Cox regression analysis, the
variables showing a significant relationship with the recurrence
was: the history of previous cancer, cancer–related neurological
symptoms, tumor size, and predilection. Previous history of
cancer with HR 6.903, 95% CI 2.925–16.292), tumor size of ≥5
cm with HR 1.842, 95% CI 1.244–2.729), and cancer–related
neurological symptoms with HR 3.818; 95% CI 1.561 –9.340)
were the prognostic factors for the recurrence. The likelihood of
such subjects to have recurrence is 95%. The cancerous lesions
in the low–risk areas were found as a protective factor of
recurrence (HR 0.071, 95% CI 0.022–0.228).

33 (17.6)
85 (45.5)
69 (36.9)

Table 4. Multivariate logistic regression analysis
Variable
Coefficient
p value
Previous cancer history
2.631
0.000
Cancer–related
neurological symptoms

2.003

0.000

Tumor size
Predilection

1.276
3.196

0.010
0.000

Constanta

–6.152

0.000

Recurrence
Yes
No

RR
(95% CI)

P

6
26

18
137

0.569
(0.206–1.570)

0.258*

10
22

11
144

5.950
(2.263–15.646)

23
9

66
89

2.956
(1.255–6.965)

0.003**

21
11

52
103

3.731
(1.696–8.433)

0.001**

28
4

107
48

3.086
(1.01–8.646)

0.034**

14
18

104
51

2.622
(1.208–5.689)

0.013***

0.001*

OR(95%CI)
13.885
(4,.008–48.107)
7.414
(2.705–20.321)
3.583
(1.364–9.408)
4.440
(5.279–113.151)
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Discussion

A better understanding of the recurrence risk factors let a more
holistic, comprehensive management and follow-up may be
provided. Out of 187 non-melanoma skin cancer enrolled in the
study, the recurrence was found in a total of 32 subjects. On the
analysis, age was not significantly associated with the recurrence
(p = 0.258) and found in contrast to study by Khan et al (2014)
reporting a median age of 78 years as the risk factors for postradiotherapy recurrence of non-melanoma cancer.9 Studies of Lin
et al (2012) showed that age had no effect on the recurrence of
BSC and SCC in the age group >70 years compared with age ≤70
years (p = 0.09; RR 1.76; 95% CI 0.92-3.37).21 Out of 187
subjects of non–melanoma enrolled in this study, the age at most
for skin cancer was over 45 (86.6%) like study of Ocanha (2009)
on BSC showing the highest prevalence of skin cancer in the
female group (54.7%) with the average age of 65 years at the
initial diagnosis constituted.17 Study of Szewczyk (2014) also on
BSC showed males were predominated (63%) with age ranged
of 32–96 years (median age 73 years).18
Study of Wiser (2016) reporting the highest prevalence of SCC
on the face and neck in the group of men with a mean age of 75
years. The study showed that gender was significantly associated
with the occurrence of SCC in the face and neck (p <0.001).19
Chren (2011) study on 495 non-melanoma showed the highest
number of male subjects (97%) with an average age at the time of
diagnosis was 71 years.6 The pathophysiology explains the
relationship between gender and the occurrence of nonmelanoma skin cancers remains unclear but may be influenced
by the habits and occupation. Males tend to have jobs with high
sun exposure let the risk of developing non-melanoma skin
cancer increased.19, 24
Out of the non-melanoma skin cancer subjects in the study, a total
of 61% were the indoor workers and did not fit to the previous
study reporting that the outdoor workers were at greater risk of
developing skin cancer. Other study reports a specific association
of BSC to intermittent sun exposure and excessive sunlight
exposure during childhood and SCC to chronic and continuous
sunlight exposure.20 In this study, most subjects were BSC and
indoor workers, Indonesian specific skin color may have an
impact different from those reported. A further investigation may
be required to have the best explanation for the difference.

analysis showing this cancer located in the face has 3 times greater
for recurrence than those located in low-risk areas (p = 0.034; RR
3.086; 95% CI 1.01-8.646). This is consistent with the previous
study by Bogelund (2007) showing that tumor sites are associated
with recurrence rates. BSC in the head region showed at a greater
risk for recurrence (OR 2.8; 95% CI 1.5-5.3).22 A systematic
review (Lansbury, 2013) showed that SCC located at the ear is at
greater risk for recurrence than other areas (14.1%, 95% CI 10, 218,5).23 The head referred to a high-risk area; as it exposed to
anything more than other parts.
The size of the tumor in this study is divided into 3 categories,
with the most category is the tumor on the skin sized 2 - ≤5 cm
that is as much as 45.5%. In the process of data analysis, we
merged the categories because the results of the analysis did not
meet the requirements of the chi-square test for a 3x2 table so that
obtained a new category that sized ≤5 cm and> 5cm. From the
results of the analysis, there was a significant correlation between
tumor size and recurrence in non-melanoma skin cancer patients
(p = 0.013; RR 2.622; 95% CI 1.208-5.689). This is in accordance
with a research by Khan et al (2014) for non-melanoma skin
cancer patients undergoing radiotherapy. The study showed that
the larger the size of the tumor, the greater the risk of recurrence
(P = 0.0004, RR 2.578, 95% CI 1.529-4.348).9 Whatever
modalities are used in the treatment of non-melanoma skin
cancer, the larger the size of the tumor, the risk of recurrence will
be even greater. The larger the size of the tumor will make it more
difficult for the surgical process because the tumor invades to the
important structures so that the risk of recurrence will increase if
the margin of the incision of the tumor is not a clear margin.
Neurological involvement of skin cancers occurs due to the
perineural infiltration process (the tumor spreads to the
perineurium of the nerve). The incidence of perineural invasion
in BSC patients ranging from 0.18% to 10%, whereas in SCC the
incidence is 2.5% to 14 %.21 Symptoms of perineural invasion
include pain, dysesthesia or hypoesthesia. In this study, it was
found that cancer-related neurologic symptoms were among the
risk factors for recurrence (P = 0.001; RR 3.731; 95% CI 1.6968.433) .21

Most subjects (93%) in this study have no family cancer history.
The history of cancer in the family is a risk factor in relation to
mutant genes that were inherited in nature. With sufficient
exposure to sunlight, particularly continuous exposure to UVA
and UVB rays may lead to precancerous lesions as these lights
leading to the mutations of p53 (tumor suppressor gene).12,15

Study of Lin et al (2012) showed that the degree of tumor
invasion of the perineurium nerve associated with tumor
recurrence within 5 years, local invasion of perineurium nerve has
better outcomes than the widespread invasion (p = 0.02; RR 2.18;
95% CI 1.11-4.31).21 Perineural invasion of skin cancers is
associated with increased recurrence possibilities due to skipping
lesions in the region along the nerve so that despite the excision is
resulting in a clear margin, the risk of recurrence remains high.
The factors associated with perineural involvement include male
gender, tumor size greater than 2 cm, location on the face, and
previous history of cancer lesions.25

BSC was found predominated (52.4%) in this study as those
reported (accounting 75% of all non-melanoma skin cancers).20
The histopathology type showed the association with the
recurrence. Bivariate analysis showed that SCC was 2.96 times
greater risk for the recurrence rather than BSC (p = 0.003; RR
2.956; 95% CI 1.255-6.965). Another important finding in the
study was the predilection. In this study, 71.7% were located in
the face, in accordance with reports showing the face as a highrisk area for the predilection of skin cancer.15 Our bivariate

In this study, we carried out survival analysis with Cox regression
to determine the factors that can be predictors of recurrence in
non-melanoma skin cancer patients who have undergone wide
excision. The results shown that previous cancer history was the
largest predictor of recurrence in patients (HR 6.903; 95% CI
2.925-16.292). It is also known that cancer lesions in low-risk
areas are a protective factor of recurrence (HR 0.071, 95% CI
0.022-0.228). This is related to the low intensity of sunlight
exposure in low-risk areas of the skin.
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The history of previous skin cancer, cancer-related neurological
symptoms, tumor size, and location of cancer have a strong
relationship with recurrence in post wide excision non-melanoma
skin cancer patients; the location of primary cancer contributes the
most to the recurrence. Cancers located in high-risk areas are three
times greater for recurrence (p = 0.034, 95% CI 1.01-8.646). This
is due to the extremely high intensity of sun exposure in high-risk
areas. The second largest risk factor was previous cancer history.
The non-melanoma skin cancer patients who had previous other
cancers and then performed wide excision then 6.9 times greater
risk for recurrence compared with patients with de novo cancer (p
= 0.000; 95% CI 2.925-16.292). Those with a history of previous
other cancers already have a mutant gene in the body let the risk
of recurrence increased. Those with perineural invasion will have
a 3.8 times greater risk of recurrence (p = 0.003, 95% CI 1.5619.340) and those with tumor size> 5cm will be 1.84 times greater
risk of recurrence (p = 0.002; 95% CI 1.244-2.729). Cumulative
risk if the subject has all the four risk factors for recurrence is 95%.
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Conclusion

In the period of January 2012 to December 2015 in CMGH, there
were 213 cases of non-melanoma skin cancer, 15% of whom had
recurrences. Factors that affect the recurrence of non-melanoma
skin cancer after wide excision include previous cancer history,
perineural invasion, cancer location, and cancer size. The
cumulative risk of recurrence for non-melanoma skin cancer
patients after wide excision located in high-risk areas, having
previous cancer history, perineural invasion, and tumor size >5
cm is 95%.
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